NEW YORK, April 12, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Apigee Corporation (“Apigee” or the “Company”) (NASDAQ:APIC) pursuant or traceable to the Company’s April 24, 2015 initial public offering.
You are hereby notified that a securities action has been commenced in the Superior Court of the State of California, County of San Mateo. If you purchased or otherwise acquired Apigee securities pursuant to the initial public offering, your rights may be affected by this action. To get more information go to: http://zlk.9nl.com/apigee.
The complaint alleges that documents filed in connection with the IPO contained materially false and misleading statements and/or failed to disclose material information, including that, among other allegations: (a) increases in revenue in the fourth quarter of 2014 and second quarter of 2015 had been inflated due to non-recurring one-time deals recognized in those quarters; (b) Apigee touted the “increasing predictability” of its revenue growth despite direct competition from Amazon; and (c) lowered demand for Apigee’s product offerings was requiring the Company to scale back on its direct sales efforts and to focus on selling through channel partners.
If you suffered a loss in Apigee and would like additional information, contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/apigee.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project 



